GGrantIndex
Sort

40,608 grants matching prostate cancer

Regulation of tumor-infiltrating T cells by macrophages

$432,678
Yiping Yang · Ohio State University · R01 · FY2022 · CA

Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells

$432,651
Dean G Tang · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA

Tumor-specific autoantibodies for SCLC early detection

$432,640
A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA

Tumor Cell Biology Training Program

$432,556
Charles F Fox · University Of California Los Angeles · T32 · FY2006 · CA

SEQUENCING TUMOR SUPPRESSOR LOCI

$432,555
Cold Spring Harbor Laboratory · R01 · FY2000 · CA

Cholesterol and Prostate Health

$432,500
Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2011 · DK

Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality

$432,473
Janet L Stanford · Fred Hutchinson Cancer Research Center · P50 · FY2018 · CA

South-Eastern Center for Imaging Animal Models of Cancer

$432,423
John C Gore · Vanderbilt University · U24 · FY2007 · CA

Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges

$432,394
Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · NS

Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges

$432,394
Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · NS

Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer

$432,349
Oliver John Semmes · Eastern Virginia Medical School · U01 · FY2018 · CA

Enhanced Cancer Risk Predictions in Underrepresented Populations through Robust Multi-Source Data Integration

$432,304
Tian Gu · Columbia University Health Sciences · R01 · FY2025 · CA

The Clinical and Epidemiological Characterization of Pathogenic DNA Damage Repair Pathway Variation in Prostate Cancer

$432,214
Kenneth Offit · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA

Long Nuclear-Retained Non-Coding RNAs and Cancer

$432,183
David L Spector · Cold Spring Harbor Laboratory · P01 · FY2012 · CA

Elucidating the somatic genetics of prostate cancer

$432,151
Matthew L Meyerson · Dana-Farber Cancer Inst · R01 · FY2008 · CA

BIOMAKERS DEVELOPMENT LABORATORY

$432,062
University Of Washington · U01 · FY2002 · CA

Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis

$432,034
Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2023 · CA

Isolation and Identification of Heterogeneous Circulating Tumor Cells Using a Microchip with Hyperuniform Patterns

$431,999
Wei Li · Texas Tech University · · FY2020 · ENG

Developmental Funds

$431,937
Kunle Odunsi · University Of Chicago · P30 · FY2022 · CA

Targeting LSD1 to prevent therapy-induced transdifferentiation in BRAF mutant colorectal cancer

$431,920
Heather M O'Hagan · Indiana University Indianapolis · R01 · FY2024 · CA

RET Regulation and Targeting in Neuroendocrine Prostate Cancer

$431,919
Justin Michael Drake · University Of Minnesota · R01 · FY2023 · CA

Tumor-specific autoantibodies for SCLC early detection

$431,826
A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

Project 2 Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function

$431,792
Qianben Wang · University Of Texas Hlth Science Center · U54 · FY2019 · CA

Stress Induction of Glucose Regulated Protein GRP78/BiP

$431,755
Amy S Lee · University Of Southern California · R01 · FY2013 · CA

Fungal Acquisition, Isolation Chemistry, Structure Elucidation, and Bioassay

$431,751
Nicholas Hunter Oberlies · Ohio State University · P01 · FY2010 · CA